Study of ADCT-301 in Patients With Relapsed/Refractory CD25-positive Acute Myeloid Leukemia (AML) or CD25-positive Acute Lymphoblastic Leukemia (ALL)

Virginia Cancer Specialists, PC, Fairfax

Duke Cancer Center, Durham

Greenville Health System, Institute for Translational Oncology Research, Greenville

Winship Cancer Institute, Emory University, Atlanta

Northside Hospital, Atlanta

Froedtert Hospital/ Medical College of Wisconsin, Milwaukee

The University of Chicago Medical Center, Chicago

The University of Texas M.D. Anderson Cancer Center, Houston

Swedish Cancer Institute, Seattle

University of Washington Medical Center, Seattle

Memorial Sloan Kettering Cancer Center, New York